Park Avenue Securities LLC Invests $396,000 in Steris PLC (STE) Stock

Park Avenue Securities LLC bought a new position in shares of Steris PLC (NYSE:STE) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,465 shares of the medical equipment provider’s stock, valued at approximately $396,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Comerica Securities Inc. increased its holdings in Steris by 54.4% during the third quarter. Comerica Securities Inc. now owns 3,489 shares of the medical equipment provider’s stock worth $399,000 after buying an additional 1,230 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its holdings in Steris by 8.3% during the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 10,480 shares of the medical equipment provider’s stock worth $1,199,000 after buying an additional 800 shares during the last quarter. WINTON GROUP Ltd acquired a new position in Steris during the third quarter worth $970,000. Meeder Asset Management Inc. increased its holdings in Steris by 129.9% during the third quarter. Meeder Asset Management Inc. now owns 5,387 shares of the medical equipment provider’s stock worth $616,000 after buying an additional 3,044 shares during the last quarter. Finally, Commerce Bank acquired a new position in Steris during the third quarter worth $249,000. Institutional investors and hedge funds own 89.52% of the company’s stock.

STE stock opened at $120.70 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.63 and a quick ratio of 2.02. Steris PLC has a one year low of $82.88 and a one year high of $121.67. The firm has a market cap of $9.93 billion, a price-to-earnings ratio of 29.08 and a beta of 1.03.

Steris (NYSE:STE) last released its quarterly earnings data on Tuesday, November 6th. The medical equipment provider reported $1.10 EPS for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.02. Steris had a net margin of 11.72% and a return on equity of 12.15%. The firm had revenue of $679.00 million during the quarter, compared to analysts’ expectations of $659.14 million. During the same period in the previous year, the business posted $0.94 earnings per share. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Steris PLC will post 4.71 earnings per share for the current fiscal year.

In other Steris news, VP Karen L. Burton sold 1,300 shares of Steris stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $114.39, for a total transaction of $148,707.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of Steris stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $120.50, for a total transaction of $1,205,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 45,800 shares of company stock valued at $5,464,727. Company insiders own 2.38% of the company’s stock.

A number of equities analysts recently weighed in on STE shares. Stephens restated a “buy” rating and set a $125.00 target price on shares of Steris in a report on Thursday, August 9th. Zacks Investment Research upgraded shares of Steris from a “sell” rating to a “hold” rating in a report on Tuesday, October 9th. JMP Securities boosted their target price on shares of Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a report on Thursday, August 9th. Finally, KeyCorp boosted their target price on shares of Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 9th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Steris presently has an average rating of “Buy” and a consensus target price of $100.86.

WARNING: “Park Avenue Securities LLC Invests $396,000 in Steris PLC (STE) Stock” was published by WKRB News and is the property of of WKRB News. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.wkrb13.com/2018/11/10/park-avenue-securities-llc-invests-396000-in-steris-plc-ste-stock.html.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

See Also: Dividend Aristocrat Index

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply